Ring Vaccination

A strategy of vaccinating close contacts of an infected person to limit disease spread.

What are Ring Vaccinations?

Ring vaccination is a targeted strategy used to control the spread of infectious diseases. Instead of vaccinating an entire population, health officials focus on identifying and vaccinating people most likely to be exposed to a case, usually the case’s close contacts, and then vaccinate the contacts of those contacts. This creates a “ring” of immune people around an infected individual, preventing further transmission.

Ring vaccination is an incredibly efficient use of limited vaccine supplies. It works best for diseases where cases can be quickly identified, the incubation period is long enough to trace contacts before they become infectious, and vaccines can provide protection either before or shortly after exposure. This strategy also requires robust surveillance systems, rapid contact tracing, and community trust. Importantly, ring vaccination shifts the focus from mass campaigns to precision public health, tailoring interventions to those at greatest risk.

This approach was key to the global eradication of smallpox, one of public health’s greatest achievements. Today, ring vaccination is often part of outbreak response plans for diseases like Ebola, monkeypox, and occasionally measles or cholera in certain settings. But it is not universally applicable. For fast-spreading respiratory infections like COVID-19 or influenza, where people become infectious before symptoms appear, ring vaccination generally is not feasible.

Why ring vaccination matters in infectious disease control

Ring vaccination allows for precision targeting of vaccines during outbreaks, maximizing impact while conserving supply.

Key conditions for successful ring vaccination

These factors determine whether ring vaccination can work effectively.

Essential requirements

• Reliable case identification
• Rapid and accurate contact tracing
• Vaccines that work post-exposure or quickly after exposure
• Community trust and participation
• Strong surveillance and reporting systems
• Adequate vaccine supply for targeted groups

Limitations of ring vaccination

• Not suitable for diseases with widespread, asymptomatic transmission
• Challenging in settings with poor surveillance or weak health systems
• Requires significant human resources for tracing and vaccination
• Potential for missed contacts leading to further spread
• Social stigma or fear can undermine participation

Ring vaccination represents precision public health in action — using focused strategies to stop disease at its source.

Example: Ebola outbreak in the Democratic Republic of Congo (2018-2020)

• Vaccine used: rVSV-ZEBOV Ebola vaccine
• Population targeted: Contacts of confirmed Ebola cases and their contacts
• Outcome: Helped prevent a much larger regional spread

Example: Monkeypox (mpox) outbreak (2022)

• Ring vaccination deployed in the U.K., Canada, and parts of the U.S.
• Focused on close contacts and sexual networks at highest risk
• Part of a layered prevention strategy alongside testing and behavior change

Ring vaccination is essential for

• Containing outbreaks of diseases with identifiable cases and contacts
• Maximizing limited vaccine supplies
• Preventing the spread of high-consequence pathogens
• Strengthening community trust through targeted outreach
• Supporting eradication or elimination goals in specific settings